Federico Lussana

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Topics

Systematic Review

Prognostic Factors

Peripheral Blood

Acute Lymphoblastic Leukemia

Top Venues

Bone marrow transplantation

American journal of hematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Castelli, Maria Caterina Micò, Anna Grassi, Alessandra Algarotti, Federico Lussana, Maria Chiara Finazzi, Benedetta Rambaldi, Chiara Pavoni, Giuliana Rizzuto, Paola Tebaldi, Francesca Vendemini, Marta Verna, Sonia Bonanomi, Andrea Biondi, Adriana Cristina Balduzzi, Alessandro Rambaldi, Giacomo Gotti
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience. Bone marrow transplantation 59 (8) (2024)
Maria Chiara Finazzi, Alessandra Weber, Chiara Pavoni, Anna Grassi, Maria Caterina Micò, Alessandra Algarotti, Federico Lussana, Alessandro Rambaldi
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation. Bone marrow transplantation 59 (6) (2024)
Maria Chiara Finazzi, Alessandra Weber, Chiara Pavoni, Anna Grassi, Maria Caterina Micò, Alessandra Algarotti, Federico Lussana, Alessandro Rambaldi
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation. Bone marrow transplantation 59 (6) (2024)
Marta Castelli, Maria Caterina Micò, Anna Grassi, Alessandra Algarotti, Federico Lussana, Maria Chiara Finazzi, Benedetta Rambaldi, Chiara Pavoni, Giuliana Rizzuto, Paola Tebaldi, Francesca Vendemini, Marta Verna, Sonia Bonanomi, Andrea Biondi, Adriana Cristina Balduzzi, Alessandro Rambaldi, Giacomo Gotti
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience. Bone marrow transplantation 59 (8) (2024)
Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, Federico Lussana, Massimo Bernardi, Claudia Basilico, Alfredo Molteni, Ivana Lotesoriere, Mauro Turrini, Marco Frigeni, Monica Fumagalli, Paola Cozzi, Federica Gigli, Chiara Cattaneo, Nicola Stefano Fracchiolla, Marta Riva, Gianluca Martini, Valentina Mancini, Roberto Cairoli, Elisabetta Todisco
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda. Cancers 16 (2) (2024)
Maria Chiara Finazzi, Alessandra Weber, Chiara Pavoni, Anna Grassi, Maria Caterina Micò, Alessandra Algarotti, Federico Lussana, Alessandro Rambaldi
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation. Bone marrow transplantation 59 (6) (2024)
Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, Federico Lussana, Massimo Bernardi, Claudia Basilico, Alfredo Molteni, Ivana Lotesoriere, Mauro Turrini, Marco Frigeni, Monica Fumagalli, Paola Cozzi, Federica Gigli, Chiara Cattaneo, Nicola Stefano Fracchiolla, Marta Riva, Gianluca Martini, Valentina Mancini, Roberto Cairoli, Elisabetta Todisco
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda. Cancers 16 (2) (2024)
Maria Chiara Finazzi, Alessandra Weber, Chiara Pavoni, Anna Grassi, Maria Caterina Micò, Alessandra Algarotti, Federico Lussana, Alessandro Rambaldi
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation. Bone marrow transplantation 59 (6) (2024)
Maria Chiara Finazzi, Alessandra Weber, Chiara Pavoni, Anna Grassi, Maria Caterina Micò, Alessandra Algarotti, Federico Lussana, Alessandro Rambaldi
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation. Bone marrow transplantation (2024)
Marta Castelli, Maria Caterina Micò, Anna Grassi, Alessandra Algarotti, Federico Lussana, Maria Chiara Finazzi, Benedetta Rambaldi, Chiara Pavoni, Giuliana Rizzuto, Paola Tebaldi, Francesca Vendemini, Marta Verna, Sonia Bonanomi, Andrea Biondi, Adriana Cristina Balduzzi, Alessandro Rambaldi, Giacomo Gotti
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience. Bone marrow transplantation (2024)
Marta Castelli, Maria Caterina Micò, Anna Grassi, Alessandra Algarotti, Federico Lussana, Maria Chiara Finazzi, Benedetta Rambaldi, Chiara Pavoni, Giuliana Rizzuto, Paola Tebaldi, Francesca Vendemini, Marta Verna, Sonia Bonanomi, Andrea Biondi, Adriana Cristina Balduzzi, Alessandro Rambaldi, Giacomo Gotti
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience. Bone marrow transplantation 59 (8) (2024)
Federico Lussana, Gianluca Cavallaro, Pantaleo De Simone, Alessandro Rambaldi
Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL. Cancers 15 (4) (2023)
Federico Lussana, Gianluca Cavallaro, Pantaleo De Simone, Alessandro Rambaldi
Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL. Cancers 15 (4) (2023)
Darina Ocadlikova, Federico Lussana, Nicola Fracchiolla, Massimiliano Bonifacio, Lidia Santoro, Mario Delia, Sabina Chiaretti, Crescenza Pasciolla, Alessandro Cignetti, Fabio Forghieri, Francesco Grimaldi, Giulia Corradi, Letizia Zannoni, Stefania De Propris, Gian Maria Borleri, Ilaria Tanasi, Jayakumar Vadakekolathu, Sergio Rutella, Anna Rita Guarini, Caterina Ilari, Antonio Curti, null null
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study. British journal of haematology (2023)
Sebastian Giebel, Myriam Labopin, Mohamed Houhou, Denis Caillot, Juergen Finke, Didier Blaise, Nathalie Fegueux, Mark Ethell, Jan J Cornelissen, Edouard Forcade, Ibrahim Yakoub Agha, Federico Lussana, Johan Maertens, Jean Henri Bourhis, Pavel Jindra, Norbert-Claude Gorin, Arnon Nagler, Florent Malard
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2023)
Federico Lussana, Gianluca Cavallaro, Pantaleo De Simone, Alessandro Rambaldi
Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL. Cancers 15 (4) (2023)
Silvia Ferrari, Chiara Caprioli, Alessandra Weber, Alessandro Rambaldi, Federico Lussana
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies. Leukemia & lymphoma 62 (6) (2021)
Federico Lussana, Giuseppe Gritti, Alessandro Rambaldi
Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (5) (2021)
Manuela Tosi, Orietta Spinelli, Matteo Leoncin, Roberta Cavagna, Chiara Pavoni, Federico Lussana, Tamara Intermesoli, Luca Frison, Giulia Perali, Francesca Carobolante, Piera Viero, Cristina Skert, Alessandro Rambaldi, Renato Bassan
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL. Cancers 13 (9) (2021)
Silvia Salmoiraghi, Roberta Cavagna, Pamela Zanghì, Chiara Pavoni, Anna Michelato, Ksenija Buklijas, Lara Elidi, Tamara Intermesoli, Federico Lussana, Elena Oldani, Chiara Caprioli, Paola Stefanoni, Giacomo Gianfaldoni, Ernesta Audisio, Elisabetta Terruzzi, Lorella De Paoli, Erika Borlenghi, Irene Cavattoni, Daniele Mattei, Annamaria Scattolin, Monica Tajana, Fabio Ciceri, Elisabetta Todisco, Leonardo Campiotti, Paolo Corradini, Nicola Fracchiolla, Renato Bassan, Alessandro Rambaldi, Orietta Spinelli
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). Cancers 12 (8) (2020)
Anna Candoni, Davide Lazzarotto, Felicetto Ferrara, Antonio Curti, Federico Lussana, Cristina Papayannidis, Maria Ilaria Del Principe, Massimiliano Bonifacio, Federico Mosna, Mario Delia, Paola Minetto, Michele Gottardi, Nicola Fracchiolla, Valentina Mancini, Fabio Forghieri, Patrizia Zappasodi, Marco Cerrano, Antonella Vitale, Ernesta Audisio, Silvia Trappolini, Claudio Romani, Marzia Defina, Silvia Imbergamo, Nadia Ciccone, Lidia Santoro, Benedetta Cambò, Salvatore Iaccarino, Michela Dargenio, Lara Aprile, Sabina Chiaretti, Renato Fanin, Giovanni Pizzolo, Roberto Foà
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study. American journal of hematology 95 (12) (2020)
Federico Lussana, Paola Minetto, Felicetto Ferrara, Sabina Chiaretti, Giorgina Specchia, Renato Bassan
National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia? BMC cancer 20 (1) (2020)
Federico Lussana, Chiara Caprioli, Paola Stefanoni, Chiara Pavoni, Orietta Spinelli, Ksenija Buklijas, Anna Michelato, GianMaria Borleri, Alessandra Algarotti, Caterina Micò, Anna Grassi, Tamara Intermesoli, Alessandro Rambaldi
Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia. Cancers 11 (10) (2019)
Federico Lussana, Marco Cattaneo, Alessandro Rambaldi, Alessandro Squizzato
Ruxolitinib-associated infections: A systematic review and meta-analysis. American journal of hematology 93 (3) (2017)
Federico Lussana, Alessandra Carobbio, Silvia Salmoiraghi, Paola Guglielmelli, Alessandro Maria Vannucchi, Barbara Bottazzi, Roberto Leone, Alberto Mantovani, Tiziano Barbui, Alessandro Rambaldi
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera. Journal of hematology & oncology 10 (1) (2017)